Journal
TRENDS IN BIOTECHNOLOGY
Volume 37, Issue 1, Pages 9-16Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2018.05.014
Keywords
-
Categories
Funding
- European Commission under the Marie Sklodowska-Curie Horizon 2020 Innovative Training Network ModLife [675251]
Ask authors/readers for more resources
The monoclonal antibody (mAb) market has changed rapidly in the past 5 years: it has doubled in size, becoming dominated by fully human molecules, launched bispecific molecules, and faced competition from biosimilars. We summarize the market in terms of therapeutic applications, type and structure of mAbs, dominant companies, manufacturing locations, and emerging markets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available